APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Urotropin for Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Urotropin for Injection Industry Growth and Trends Forecast to 2032

Report ID 174044690122 December 2025111 pages

Choose your research edition.

Industry ResearchUrotropin for Injection Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Urotropin for Injection Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Urotropin for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urotropin for Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Urotropin for Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Urotropin for Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Urotropin for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Urotropin for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Urotropin for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Urotropin for Injection include Yantai Dongcheng North Pharmaceutical, Teva, Shanghai Tianwei Biopharmaceutical Co., Ltd., Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd., Qingdao Kangyuan Pharmaceutical, Ningbo Human Health Pharmaceutical Group, Ningbo Human Health Pharmaceutical, Merck and Maanshan Fengyuan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Urotropin for Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Urotropin for Injection market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Urotropin for Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Urotropin for Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Urotropin for Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Urotropin for Injection Market by Company

Yantai Dongcheng North Pharmaceutical

Teva

Shanghai Tianwei Biopharmaceutical Co., Ltd.

Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd.

Qingdao Kangyuan Pharmaceutical

Ningbo Human Health Pharmaceutical Group

Ningbo Human Health Pharmaceutical

Merck

Maanshan Fengyuan Pharmaceutical

Livzon Group

Ferring GmbH

Livzon

IBSA Group

GenSci

Gedeon Richter

Urotropin for Injection Segment by Type

75 Unit

150 Unit

Urotropin for Injection Segment by Application

Hospital

Clinic

Urotropin for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urotropin for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urotropin for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urotropin for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Urotropin for Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Urotropin for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 75 Unit Table 2. Major Company of 150 Unit Table 3. Global Urotropin for Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Urotropin for Injection Sales by Type (2021-2026) & (k units) Table 5. Global Urotropin for Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Urotropin for Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Urotropin for Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Urotropin for Injection Price by Type (2021-2026) & (US$/unit) Table 9. Global Urotropin for Injection Sales by Type (2027-2032) & (k units) Table 10. Global Urotropin for Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Urotropin for Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Urotropin for Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Urotropin for Injection Price by Type (2027-2032) & (US$/unit) Table 14. North America Urotropin for Injection Sales by Type (2021-2026) & (k units) Table 15. North America Urotropin for Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Urotropin for Injection Sales by Type (2021-2026) & (k units) Table 17. Europe Urotropin for Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Urotropin for Injection Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Urotropin for Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Urotropin for Injection Sales by Type (2021-2026) & (k units) Table 21. Latin America Urotropin for Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Urotropin for Injection Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Urotropin for Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Urotropin for Injection Industry Trends Table 25. Urotropin for Injection Industry Drivers Table 26. Urotropin for Injection Industry Opportunities and Challenges Table 27. Urotropin for Injection Industry Restraints Table 28. Global Urotropin for Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Urotropin for Injection Revenue Market Share by Company (2021-2026) Table 30. Global Urotropin for Injection Sales by Company (2021-2026) & (k units) Table 31. Global Urotropin for Injection Sales Share by Company (2021-2026) Table 32. Global Urotropin for Injection Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Urotropin for Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Urotropin for Injection Major Company Production Sites and Headquarters Table 35. Global Urotropin for Injection Company, Product Type & Application Table 36. Global Urotropin for Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Urotropin for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Urotropin for Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Urotropin for Injection Sales by Region (2021-2026) & (k units) Table 41. Global Urotropin for Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Urotropin for Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Urotropin for Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Urotropin for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Urotropin for Injection Sales by Region (2027-2032) & (k units) Table 46. Global Urotropin for Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Urotropin for Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Urotropin for Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Urotropin for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Urotropin for Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Urotropin for Injection Sales by Application (2021-2026) & (k units) Table 52. Global Urotropin for Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Urotropin for Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Urotropin for Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Urotropin for Injection Price by Application (2021-2026) & (US$/unit) Table 56. Global Urotropin for Injection Sales by Application (2027-2032) & (k units) Table 57. Global Urotropin for Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Urotropin for Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Urotropin for Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Urotropin for Injection Price by Application (2027-2032) & (US$/unit) Table 61. North America Urotropin for Injection Sales by Application (2021-2026) & (k units) Table 62. North America Urotropin for Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Urotropin for Injection Sales by Application (2021-2026) & (k units) Table 64. Europe Urotropin for Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Urotropin for Injection Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Urotropin for Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Urotropin for Injection Sales by Application (2021-2026) & (k units) Table 68. Latin America Urotropin for Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Urotropin for Injection Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Urotropin for Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Yantai Dongcheng North Pharmaceutical Company Information Table 72. Yantai Dongcheng North Pharmaceutical Business Overview Table 73. Yantai Dongcheng North Pharmaceutical Urotropin for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Yantai Dongcheng North Pharmaceutical Urotropin for Injection Product Portfolio Table 75. Yantai Dongcheng North Pharmaceutical Recent Development Table 76. Teva Company Information Table 77. Teva Business Overview Table 78. Teva Urotropin for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Teva Urotropin for Injection Product Portfolio Table 80. Teva Recent Development Table 81. Shanghai Tianwei Biopharmaceutical Co., Ltd. Company Information Table 82. Shanghai Tianwei Biopharmaceutical Co., Ltd. Business Overview Table 83. Shanghai Tianwei Biopharmaceutical Co., Ltd. Urotropin for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Shanghai Tianwei Biopharmaceutical Co., Ltd. Urotropin for Injection Product Portfolio Table 85. Shanghai Tianwei Biopharmaceutical Co., Ltd. Recent Development Table 86. Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Company Information Table 87. Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Business Overview Table 88. Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Urotropin for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Urotropin for Injection Product Portfolio Table 90. Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Recent Development Table 91. Qingdao Kangyuan Pharmaceutical Company Information Table 92. Qingdao Kangyuan Pharmaceutical Business Overview Table 93. Qingdao Kangyuan Pharmaceutical Urotropin for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Qingdao Kangyuan Pharmaceutical Urotropin for Injection Product Portfolio Table 95. Qingdao Kangyuan Pharmaceutical Recent Development Table 96. Ningbo Human Health Pharmaceutical Group Company Information Table 97. Ningbo Human Health Pharmaceutical Group Business Overview Table 98. Ningbo Human Health Pharmaceutical Group Urotropin for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Ningbo Human Health Pharmaceutical Group Urotropin for Injection Product Portfolio Table 100. Ningbo Human Health Pharmaceutical Group Recent Development Table 101. Ningbo Human Health Pharmaceutical Company Information Table 102. Ningbo Human Health Pharmaceutical Business Overview Table 103. Ningbo Human Health Pharmaceutical Urotropin for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Ningbo Human Health Pharmaceutical Urotropin for Injection Product Portfolio Table 105. Ningbo Human Health Pharmaceutical Recent Development Table 106. Merck Company Information Table 107. Merck Business Overview Table 108. Merck Urotropin for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Merck Urotropin for Injection Product Portfolio Table 110. Merck Recent Development Table 111. Maanshan Fengyuan Pharmaceutical Company Information Table 112. Maanshan Fengyuan Pharmaceutical Business Overview Table 113. Maanshan Fengyuan Pharmaceutical Urotropin for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Maanshan Fengyuan Pharmaceutical Urotropin for Injection Product Portfolio Table 115. Maanshan Fengyuan Pharmaceutical Recent Development Table 116. Livzon Group Company Information Table 117. Livzon Group Business Overview Table 118. Livzon Group Urotropin for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Livzon Group Urotropin for Injection Product Portfolio Table 120. Livzon Group Recent Development Table 121. Ferring GmbH Company Information Table 122. Ferring GmbH Business Overview Table 123. Ferring GmbH Urotropin for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Ferring GmbH Urotropin for Injection Product Portfolio Table 125. Ferring GmbH Recent Development Table 126. Livzon Company Information Table 127. Livzon Business Overview Table 128. Livzon Urotropin for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Livzon Urotropin for Injection Product Portfolio Table 130. Livzon Recent Development Table 131. IBSA Group Company Information Table 132. IBSA Group Business Overview Table 133. IBSA Group Urotropin for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. IBSA Group Urotropin for Injection Product Portfolio Table 135. IBSA Group Recent Development Table 136. GenSci Company Information Table 137. GenSci Business Overview Table 138. GenSci Urotropin for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. GenSci Urotropin for Injection Product Portfolio Table 140. GenSci Recent Development Table 141. Gedeon Richter Company Information Table 142. Gedeon Richter Business Overview Table 143. Gedeon Richter Urotropin for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Gedeon Richter Urotropin for Injection Product Portfolio Table 145. Gedeon Richter Recent Development Table 146. North America Urotropin for Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. North America Urotropin for Injection Sales by Country (2021-2026) & (k units) Table 148. North America Urotropin for Injection Sales Market Share by Country (2021-2026) Table 149. North America Urotropin for Injection Sales Forecast by Country (2027-2032) & (k units) Table 150. North America Urotropin for Injection Sales Market Share Forecast by Country (2027-2032) Table 151. North America Urotropin for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Urotropin for Injection Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Urotropin for Injection Market Share by Country (2021-2026) Table 154. North America Urotropin for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Urotropin for Injection Market Share Forecast by Country (2027-2032) Table 156. Europe Urotropin for Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Europe Urotropin for Injection Sales by Country (2021-2026) & (k units) Table 158. Europe Urotropin for Injection Sales Market Share by Country (2021-2026) Table 159. Europe Urotropin for Injection Sales Forecast by Country (2027-2032) & (k units) Table 160. Europe Urotropin for Injection Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Urotropin for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Urotropin for Injection Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Urotropin for Injection Market Share by Country (2021-2026) Table 164. Europe Urotropin for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Urotropin for Injection Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Urotropin for Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Urotropin for Injection Sales by Country (2021-2026) & (k units) Table 168. Asia-Pacific Urotropin for Injection Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Urotropin for Injection Sales Forecast by Country (2027-2032) & (k units) Table 170. Asia-Pacific Urotropin for Injection Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Urotropin for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Urotropin for Injection Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Urotropin for Injection Market Share by Country (2021-2026) Table 174. Asia-Pacific Urotropin for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Urotropin for Injection Market Share Forecast by Country (2027-2032) Table 176. Latin America Urotropin for Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Latin America Urotropin for Injection Sales by Country (2021-2026) & (k units) Table 178. Latin America Urotropin for Injection Sales Market Share by Country (2021-2026) Table 179. Latin America Urotropin for Injection Sales Forecast by Country (2027-2032) & (k units) Table 180. Latin America Urotropin for Injection Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Urotropin for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Urotropin for Injection Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Urotropin for Injection Market Share by Country (2021-2026) Table 184. Latin America Urotropin for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Urotropin for Injection Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Urotropin for Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Urotropin for Injection Sales by Country (2021-2026) & (k units) Table 188. Middle East and Africa Urotropin for Injection Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Urotropin for Injection Sales Forecast by Country (2027-2032) & (k units) Table 190. Middle East and Africa Urotropin for Injection Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Urotropin for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Urotropin for Injection Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Urotropin for Injection Market Share by Country (2021-2026) Table 194. Middle East and Africa Urotropin for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Urotropin for Injection Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Urotropin for Injection Distributors List Table 199. Urotropin for Injection Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Urotropin for Injection Image Figure 2. Global Urotropin for Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urotropin for Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Urotropin for Injection Sales (2021-2032) & (k units) Figure 5. 75 Unit Image Figure 6. Global 75 Unit Sales YoY Growth (2021-2032) & (k units) Figure 7. 150 Unit Image Figure 8. Global 150 Unit Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Urotropin for Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Urotropin for Injection Market Share by Type 2025 VS 2032 Figure 11. North America Urotropin for Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Urotropin for Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Urotropin for Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Urotropin for Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Urotropin for Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Urotropin for Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Urotropin for Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Urotropin for Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Urotropin for Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Urotropin for Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Urotropin for Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Urotropin for Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Urotropin for Injection Market Share by Application 2025 VS 2032 Figure 29. North America Urotropin for Injection Sales Market Share in Volume by Application in 2025 Figure 30. North America Urotropin for Injection Sales Market Share in Value by Application in 2025 Figure 31. Europe Urotropin for Injection Sales Market Share in Volume by Application in 2025 Figure 32. Europe Urotropin for Injection Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Urotropin for Injection Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Urotropin for Injection Sales Market Share in Value by Application in 2025 Figure 35. Latin America Urotropin for Injection Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Urotropin for Injection Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Urotropin for Injection Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Urotropin for Injection Sales Market Share in Value by Application in 2025 Figure 39. North America Urotropin for Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Urotropin for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Urotropin for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Urotropin for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Urotropin for Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Urotropin for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Urotropin for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Urotropin for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Urotropin for Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Urotropin for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Urotropin for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Urotropin for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Urotropin for Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Urotropin for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Urotropin for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Urotropin for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Urotropin for Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Urotropin for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Urotropin for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Urotropin for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Urotropin for Injection Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Urotropin for Injection Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 75 Unit
  • 150 Unit
Applications
  • Hospital
  • Clinic
Companies covered
  • Yantai Dongcheng North Pharmaceutical
  • Teva
  • Shanghai Tianwei Biopharmaceutical Co., Ltd.
  • Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd.
  • Qingdao Kangyuan Pharmaceutical
  • Ningbo Human Health Pharmaceutical Group
  • Ningbo Human Health Pharmaceutical
  • Merck
  • Maanshan Fengyuan Pharmaceutical
  • Livzon Group
  • Ferring GmbH
  • Livzon
  • IBSA Group
  • GenSci
  • Gedeon Richter

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Urotropin for Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Urotropin for Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Urotropin for Injection Market by Type
  6. 1.3.1 75 Unit
  7. 1.3.2 150 Unit
  8. 1.4 Global Urotropin for Injection Market Size by Type
  9. 1.4.1 Global Urotropin for Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Urotropin for Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Urotropin for Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Urotropin for Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Urotropin for Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Urotropin for Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Urotropin for Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Urotropin for Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Urotropin for Injection Industry Trends
  2. 2.2 Urotropin for Injection Industry Drivers
  3. 2.3 Urotropin for Injection Industry Opportunities and Challenges
  4. 2.4 Urotropin for Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Urotropin for Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Urotropin for Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Urotropin for Injection Price (2021-2026)
  4. 3.4 Global Urotropin for Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Urotropin for Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Urotropin for Injection Company, Product Type & Application
  7. 3.7 Global Urotropin for Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Urotropin for Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Urotropin for Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Urotropin for Injection Tier 1, Tier 2, and Tier 3
4 Urotropin for Injection Regional Status and Outlook
  1. 4.1 Global Urotropin for Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Urotropin for Injection Historic Market Size by Region
  3. 4.2.1 Global Urotropin for Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Urotropin for Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Urotropin for Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Urotropin for Injection Forecasted Market Size by Region
  7. 4.3.1 Global Urotropin for Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Urotropin for Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Urotropin for Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Urotropin for Injection by Application
  1. 5.1 Urotropin for Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Urotropin for Injection Market Size by Application
  5. 5.2.1 Global Urotropin for Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Urotropin for Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Urotropin for Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Urotropin for Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Urotropin for Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Urotropin for Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Urotropin for Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Urotropin for Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yantai Dongcheng North Pharmaceutical
  2. 6.1.1 Yantai Dongcheng North Pharmaceutical Company Information
  3. 6.1.2 Yantai Dongcheng North Pharmaceutical Business Overview
  4. 6.1.3 Yantai Dongcheng North Pharmaceutical Urotropin for Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yantai Dongcheng North Pharmaceutical Urotropin for Injection Product Portfolio
  6. 6.1.5 Yantai Dongcheng North Pharmaceutical Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Urotropin for Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Urotropin for Injection Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Shanghai Tianwei Biopharmaceutical Co., Ltd.
  14. 6.3.1 Shanghai Tianwei Biopharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Shanghai Tianwei Biopharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Shanghai Tianwei Biopharmaceutical Co., Ltd. Urotropin for Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Tianwei Biopharmaceutical Co., Ltd. Urotropin for Injection Product Portfolio
  18. 6.3.5 Shanghai Tianwei Biopharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd.
  20. 6.4.1 Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Urotropin for Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Urotropin for Injection Product Portfolio
  24. 6.4.5 Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Qingdao Kangyuan Pharmaceutical
  26. 6.5.1 Qingdao Kangyuan Pharmaceutical Company Information
  27. 6.5.2 Qingdao Kangyuan Pharmaceutical Business Overview
  28. 6.5.3 Qingdao Kangyuan Pharmaceutical Urotropin for Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Qingdao Kangyuan Pharmaceutical Urotropin for Injection Product Portfolio
  30. 6.5.5 Qingdao Kangyuan Pharmaceutical Recent Developments
  31. 6.6 Ningbo Human Health Pharmaceutical Group
  32. 6.6.1 Ningbo Human Health Pharmaceutical Group Company Information
  33. 6.6.2 Ningbo Human Health Pharmaceutical Group Business Overview
  34. 6.6.3 Ningbo Human Health Pharmaceutical Group Urotropin for Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ningbo Human Health Pharmaceutical Group Urotropin for Injection Product Portfolio
  36. 6.6.5 Ningbo Human Health Pharmaceutical Group Recent Developments
  37. 6.7 Ningbo Human Health Pharmaceutical
  38. 6.7.1 Ningbo Human Health Pharmaceutical Company Information
  39. 6.7.2 Ningbo Human Health Pharmaceutical Business Overview
  40. 6.7.3 Ningbo Human Health Pharmaceutical Urotropin for Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Ningbo Human Health Pharmaceutical Urotropin for Injection Product Portfolio
  42. 6.7.5 Ningbo Human Health Pharmaceutical Recent Developments
  43. 6.8 Merck
  44. 6.8.1 Merck Company Information
  45. 6.8.2 Merck Business Overview
  46. 6.8.3 Merck Urotropin for Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Merck Urotropin for Injection Product Portfolio
  48. 6.8.5 Merck Recent Developments
  49. 6.9 Maanshan Fengyuan Pharmaceutical
  50. 6.9.1 Maanshan Fengyuan Pharmaceutical Company Information
  51. 6.9.2 Maanshan Fengyuan Pharmaceutical Business Overview
  52. 6.9.3 Maanshan Fengyuan Pharmaceutical Urotropin for Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Maanshan Fengyuan Pharmaceutical Urotropin for Injection Product Portfolio
  54. 6.9.5 Maanshan Fengyuan Pharmaceutical Recent Developments
  55. 6.10 Livzon Group
  56. 6.10.1 Livzon Group Company Information
  57. 6.10.2 Livzon Group Business Overview
  58. 6.10.3 Livzon Group Urotropin for Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Livzon Group Urotropin for Injection Product Portfolio
  60. 6.10.5 Livzon Group Recent Developments
  61. 6.11 Ferring GmbH
  62. 6.11.1 Ferring GmbH Company Information
  63. 6.11.2 Ferring GmbH Business Overview
  64. 6.11.3 Ferring GmbH Urotropin for Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Ferring GmbH Urotropin for Injection Product Portfolio
  66. 6.11.5 Ferring GmbH Recent Developments
  67. 6.12 Livzon
  68. 6.12.1 Livzon Company Information
  69. 6.12.2 Livzon Business Overview
  70. 6.12.3 Livzon Urotropin for Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Livzon Urotropin for Injection Product Portfolio
  72. 6.12.5 Livzon Recent Developments
  73. 6.13 IBSA Group
  74. 6.13.1 IBSA Group Company Information
  75. 6.13.2 IBSA Group Business Overview
  76. 6.13.3 IBSA Group Urotropin for Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 IBSA Group Urotropin for Injection Product Portfolio
  78. 6.13.5 IBSA Group Recent Developments
  79. 6.14 GenSci
  80. 6.14.1 GenSci Company Information
  81. 6.14.2 GenSci Business Overview
  82. 6.14.3 GenSci Urotropin for Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 GenSci Urotropin for Injection Product Portfolio
  84. 6.14.5 GenSci Recent Developments
  85. 6.15 Gedeon Richter
  86. 6.15.1 Gedeon Richter Company Information
  87. 6.15.2 Gedeon Richter Business Overview
  88. 6.15.3 Gedeon Richter Urotropin for Injection Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Gedeon Richter Urotropin for Injection Product Portfolio
  90. 6.15.5 Gedeon Richter Recent Developments
7 North America by Country
  1. 7.1 North America Urotropin for Injection Sales by Country
  2. 7.1.1 North America Urotropin for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Urotropin for Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Urotropin for Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Urotropin for Injection Market Size by Country
  6. 7.2.1 North America Urotropin for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Urotropin for Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Urotropin for Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Urotropin for Injection Sales by Country
  2. 8.1.1 Europe Urotropin for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Urotropin for Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Urotropin for Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Urotropin for Injection Market Size by Country
  6. 8.2.1 Europe Urotropin for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Urotropin for Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Urotropin for Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Urotropin for Injection Sales by Country
  2. 9.1.1 Asia-Pacific Urotropin for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Urotropin for Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Urotropin for Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Urotropin for Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Urotropin for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Urotropin for Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Urotropin for Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Urotropin for Injection Sales by Country
  2. 10.1.1 South America Urotropin for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Urotropin for Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Urotropin for Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Urotropin for Injection Market Size by Country
  6. 10.2.1 South America Urotropin for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Urotropin for Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Urotropin for Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Urotropin for Injection Sales by Country
  2. 11.1.1 Middle East and Africa Urotropin for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Urotropin for Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Urotropin for Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Urotropin for Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Urotropin for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Urotropin for Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Urotropin for Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Urotropin for Injection Value Chain Analysis
  2. 12.1.1 Urotropin for Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Urotropin for Injection Production Mode & Process
  7. 12.2 Urotropin for Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Urotropin for Injection Distributors
  10. 12.2.3 Urotropin for Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst